Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 15, 2025

Conditions

Dermatophyte Infection

Interventions

DRUG

Voriconazole high dose

Oral voriconazole 200mg once a day for a maximum of 28 days

DRUG

Voriconazole low dose

Oral voriconazole 200mg twice a day for a maximum of 28 days

Trial Locations (1)

Sheikh zayed Medical College and Hospital, Rahim Yar Khan

All Listed Sponsors

lead

Sheikh Zayed Medical College

OTHER_GOV

NCT06680544 - Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections | Biotech Hunter | Biotech Hunter